Abiomed, Inc.ABMDNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+6.1%
5Y CAGR-4.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+6.1%/yr
vs +6.8%/yr prior
5Y CAGR
-4.0%/yr
Recent acceleration
Acceleration
-0.7pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2022 | 26.72% |
| 2021 | -2.17% |
| 2020 | 6.24% |
| 2019 | 22.39% |
| 2018 | 20.44% |
| 2017 | 32.81% |
| 2016 | 30.65% |
| 2015 | 17.23% |
| 2014 | 27.34% |
| 2013 | 17.45% |